Norway· NO-ID_871D051A-66EA-4606-9DF4-EA634A6E5571

Nepresol

A dihydralazine product containing dihydralazin, registered in Norway by Teofarma S.r.l. The same ATC class is registered in 4 of our 19 countries.

ATC C02DB01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedNepresolATCC02DB01REGISTER NO.NO-ID_871D051A-66EA-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Dihydralazine is registered in 4 of 19 countries.

Countries holding a registration under ATC C02DB01 (dihydralazine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Dihydralazine · ATC C02DB01

4 / 19 countries

  • Finlandprice
  • Franceprice
  • Germany
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Dihydralazin
Manufacturer
Teofarma S.r.l
Country
Norway (NO)
ATC code
C02DB01
ATC class
Dihydralazine
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_871D051A-66EA-4606-9DF4-EA634A6E5571
  • no_varenummer
    260984
    5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dihydralazine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dihydralazine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Nepresol
  • France · Nepressol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa170c06-36bd-4337-8b52-c91040ba94a7
GET /v1/drugs/aa170c06-36bd-4337-8b52-c91040ba94a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver og væske til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Dihydralazin",
  "merkevare_id": "ID_871D051A-66EA-4606-9DF4-EA634A6E5571",
  "name_form_strength": "Nepresol pulv+væske til inj oppl 25 mg",
  "prescription_group": "C"
}

See everything about dihydralazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.